© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Benzoylmetronidazole stands out among chemical compounds for its unique mixture of practical uses and notable molecular structure. Recognized by its IUPAC name, this chemical links the benzoic acid group to metronidazole, creating a solid that finds applications mainly in pharmaceutical raw materials and research. Looking at its structure reveals a core that unites both hydrophobic and hydrophilic elements, giving rise to properties valued in both formulating new drugs and performing analytical research. What often brings questions is not just how the molecule works, but how it behaves at a physical and practical level, especially when handled in bulk or research environments. Its CAS registry number offers a handle for regulatory databases and chemical platforms to track its trade and use, but seeing it up close, the real interest lies in its varied material forms and specifications that matter on the lab bench or production room floor.
Looking at Benzoylmetronidazole, the chemical presents as a fine powder or sometimes a crystalline solid, off-white to pale in color, easily mistaken for other benzoic derivatives until a closer examination of its particulate form. It holds a molecular formula of C13H11N3O4, showing a molecular weight of roughly 273.25 g/mol, not particularly large among organic chemicals, but dense enough to resist easy dispersion. In typical storage, the density measures around 1.4 g/cm³, which places it within the normal range for solid pharmaceuticals, balancing bulk transport needs with manageable handling for end users. Each flake or Pearl, whether appearing as a dusting or as compacted solid, reflects light unevenly, a tell-tale sign of interspersed amorphous and crystalline zones, nearly always a trait of synthesis techniques used in industry. Solutions created with Benzoylmetronidazole, often held in ethanol for analytical work, show moderate stability, breaking down only when exposed to strong acids or bases. That kind of behavior tells a lot about how the molecule will stand up to processing during pharmaceutical synthesis or chemical analysis and how workers may need to approach containment and transfer.
Specifications usually list the melting point, which sits close to 140–145°C, just high enough to keep the material solid under normal storage or transport conditions but low enough for laboratory teams to melt and re-solidify during materials testing. Most suppliers keep particle size between 80–120 mesh for powder, which balances reactivity and dosing precision in medical manufacturing. Some distributors offer the substance in small pearls or pellets, a form chosen for better flow through automatic dispensing equipment, especially where dust suppression is critical for safety. Bulk shipments often arrive sealed in polyethylene or glass containers, protected from light and moisture, since the material does degrade with long-term exposure, changing both physical appearance and medicinal potency. Each lot typically comes with an assay result, which most labs want to be above 98% purity, plus a residual solvents test, both required for registration under many national import and export regimes.
Movement through customs channels relies on the Harmonized System code, most frequently entered under HS Code 293329, which covers heterocyclic compounds with nitrogen atoms outside the ring system. This tagging streamlines regulatory review for international shipment. Importers know to expect detailed safety data sheets (SDS) and documentation to prove the material’s hazard classification matches GHS and local rules – not just for transparency, but because authorities want clear proof that handlers understand both the toxic and the flammable potential associated with the chemical. As someone who has organized bulk shipments before, clarity on HS Code and documentation can mean the difference between smooth processing or costly delays at port, a reality that supply managers watch closely when planning procurement.
Anyone with real experience on the factory or laboratory floor knows that Benzoylmetronidazole is not particularly volatile, but like many nitroimidazole derivatives, it demands careful handling. The powder, while dense, disperses enough to be an inhalation irritant, and direct skin contact sometimes leads to mild irritation in sensitive users. Its material safety data points to toxicological risks mostly relevant if ingested or if exposed over time at high concentrations. Weighted against other research chemicals, benzoylmetronidazole rates a bit lower on acute hazard scales, but proper storage – in cool, well-ventilated places away from acids and oxidants – keeps accidental reactions from developing. In larger production settings, workers rely on gloves, dust masks, and dedicated handling stations to keep exposure risks as low as technical feasibility allows. Labs conducting testing usually apply closed-system weighing and mixing when preparing liter-scale solutions, minimizing any environmental release, both for personal safety and for regulatory compliance.
Benzoylmetronidazole shows low volatility, so it’s less of a danger in terms of inhalation than some other fine powders, though direct eye or mucous membrane exposure brings real irritation. Chronic toxicity data mostly relates to its base metronidazole group, with mutagenicity and carcinogenicity discussed in the literature, so downstream product developers and safety officers take care to limit environmental and handler exposure at all stages. Accidental combustion doesn’t release highly toxic gases, but it will form basic oxides of carbon and nitrogen, so designated chemical waste disposal offers the safest conclusion to any spill or off-spec material. Including robust safety procedures in work instructions makes practical sense, not just to meet legal obligations, but to embed safe culture at the user level, especially in busy research, production, or warehouse environments.
Downstream industries using Benzoylmetronidazole select suppliers based on traceability and batch consistency. Raw materials get scrutinized for heavy metal content and residual organic solvents, both of which can undermine product safety and legal compliance. Pharmacopeial or customer-driven specifications push manufacturers to tighten quality management from synthesis through final packaging. Often, this substance acts as a key intermediate for other compounds, so the entire supply chain looks for transparent third-party testing and regular certification updates. Any breakdown of communication between source and end user risks not only delay or regulatory dispute, but also long-term quality shortfalls that end up costing more through recalls or material rejection.
Looking at ways to reduce risk and promote safer handling, a few strategies stand out: real-time dust monitoring in production plants can flag unsafe exposure before it reaches harmful levels. Regular user training makes sense for any site managing more than a kilogram at a time, so staff understand both spill response and daily practice. On the regulatory side, digitized batch traceability pairs with SDS automation to give everyone from warehouse loaders to customs officers instant access to ingredient data and hazard ratings. At the industry level, collaboration among producers and end users, both to develop best practice standards and to share anonymized incident reports, strengthens the overall safety culture and reduces repetitive mishaps. This approach, grounded in experience and careful attention to detail, gives every link in the supply chain a fighting chance to manage Benzoylmetronidazole with both effectiveness and care.
